Evaluate is boosting its forecasting practice with the acquisition of J+D Forecasting and its pharma industry software solutions.
Evaluate, known for its consensus data and forecasting, has worked with J+D over the past few years on projects, supplying data for J+D software modeling, and found the two were a good fit, Evaluate chief revenue officer Chris Kelley said.
“We have the data that customers subscribe to and also consulting strategy to help them with sizing a market, looking at entering a new indication, looking at buying a company — and competitive intelligence forecasting plays a big part in all of those decisions and areas,” he said. “What we haven’t had, but our customers use either by creating it on their own or buying it from someone else, is a workflow tool to build up their own bottom-up internal forecasting.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.